Crossref
Claudin 18.2 in pancreatic neuroendocrine tumors: a potential therapeutic target
Endocrine Abstracts · 04.03.2026
DOI: 10.1530/endoabs.116.b13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von Sarah Fu, und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fu,, S., Sidhom, F., Guenter, R., Jain, E., Jaskula-Sztul, R., & Gupta, G. (2026). Claudin 18.2 in pancreatic neuroendocrine tumors: a potential therapeutic target. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.b13
Vancouver
Fu, S, Sidhom F, Guenter R, Jain E, Jaskula-Sztul R, Gupta G. Claudin 18.2 in pancreatic neuroendocrine tumors: a potential therapeutic target. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.b13
BibTeX
@article{Fu2026,
author = {Fu,, Sarah and Sidhom, Fady and Guenter, Rachael and Jain, Ekta and Jaskula-Sztul, Renata and Gupta, Garima},
title = {Claudin 18.2 in pancreatic neuroendocrine tumors: a potential therapeutic target},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.116.b13}
}
EUVIMED